Watson Files ANDA For Mucinex DM, Gets In Line For Generic Guaifenesin
This article was originally published in The Tan Sheet
Executive Summary
Watson Pharmaceuticals appears to be the first firm to file an abbreviated new drug application with FDA to market a private label version of Reckitt Benckiser's Mucinex DM